Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators (see Appendix 1). Harbeck N, et al. Among authors: rath p. Ann Oncol. 2023 Aug;34(8):660-669. doi: 10.1016/j.annonc.2023.05.003. Epub 2023 May 16. Ann Oncol. 2023. PMID: 37201751 Free article. Clinical Trial.
Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy.
Harbeck N, Kates R, Schinköthe T, Schumacher J, Wuerstlein R, Degenhardt T, Lüftner D, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Fasching PA, Schmidt M; AGO-B, WSG PreCycle investigators. Harbeck N, et al. Among authors: rath p. Cancer Treat Rev. 2023 Dec;121:102631. doi: 10.1016/j.ctrv.2023.102631. Epub 2023 Oct 18. Cancer Treat Rev. 2023. PMID: 37862832 Review.
Multimodal Quality Initiatives in Sepsis Care: Assessing Impact on Core Measures and Outcomes.
Garcia M, Al-Jaghbeer M, Morrison J, Boustany A, Ghimire B, Tapryal N, Mushtaq K, Orlosky K, Flowers-Surovi A, Murphy C, Rath P, Rahman M, Kickel C, Lee YC, Chang KY, Abi Fadel F. Garcia M, et al. Among authors: rath p. J Healthc Qual. 2024 May 17. doi: 10.1097/JHQ.0000000000000440. Online ahead of print. J Healthc Qual. 2024. PMID: 38759142
Association between Usage of Prophylactic AYUSH Medicines and Disease Severity in COVID-19 Patients: A Retrospective Cohort Study.
Chaudhary A, Nayak D, Pandey S, Shastri V, Kamble M, Pendse V, Prajapati V, Vaidya B, Rohit H, Beedmani S, Presswala N, Patole T, Bawaskar R, Shinde V, Datta M, Rai G, Prusty U, Pal PP, Goli SP, Sahoo AR, Muraleedharan KC, Prakash P, Mahajan A, Singh A, Krishnan R, Pawaskar N, Srivastava A, Ningthoujam GD, Sadarla RK, Sonny R, Karso L, Sarkar S, Prasad S, Shrivastava AK, Kumar A, Kumar N, Raveendar C, Kumar BR, Sastry V, Dasari A, Sundeep KS, Kaushik S, Rath P, Gautam S, Shil RC, Swain TL, Reddy GRC, Pradeep S, Stevenson S, Choubey G, Debata L, Khurana A. Chaudhary A, et al. Among authors: rath p. Homeopathy. 2024 May 7. doi: 10.1055/s-0044-1779693. Online ahead of print. Homeopathy. 2024. PMID: 38714214 Free article.
Heart failure, the global pandemic: A call to action consensus statement from the global presidential conclave at the platinum jubilee conference of cardiological society of India 2023.
Harikrishnan S, Rath PC, Bang V, McDonagh T, Ogola E, Silva H, Rajbanshi BG, Pathirana A, Ng GA, Biga C, Lüscher TF, Daggubati R, Adivi S, Roy D, Banerjee PS, Das MK. Harikrishnan S, et al. Among authors: rath pc. Indian Heart J. 2024 Apr 10:S0019-4832(24)00057-9. doi: 10.1016/j.ihj.2024.04.004. Online ahead of print. Indian Heart J. 2024. PMID: 38609052 Free article. Review.
518 results